Prometheus Laboratories (@prometheuslab) 's Twitter Profile
Prometheus Laboratories

@prometheuslab

A leader of precision healthcare in gastroenterology, offering novel diagnostic testing services to help physicians provide the highest level of patient care

ID: 1387838741155172353

linkhttps://prometheuslabs.com calendar_today29-04-2021 18:39:14

205 Tweet

61 Followers

111 Following

Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

We’re excited to announce the official launch of the Respondr® TNF test! With the addition of this test to our portfolio, providers can now utilize one lab to support inflammatory bowel disease (IBD) patients through the entire patient care journey, from diagnosis to achieving

We’re excited to announce the official launch of the Respondr® TNF test! With the addition of this test to our portfolio, providers can now utilize one lab to support inflammatory bowel disease (IBD) patients through the entire patient care journey, from diagnosis to achieving
Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

If you’re in San Diego, come see us at DDW booth 2129. We’d love to talk about the latest advances in precision-guided therapy selection with Respondr® and biologic therapy optimization with PredictrPK®. #DDW2025 #Gastroenterology #GITwitter #IBD #IBDTwitter #GI #GIHealth

If you’re in San Diego, come see us at DDW booth 2129. We’d love to talk about the latest advances in precision-guided therapy selection with Respondr® and biologic therapy optimization with PredictrPK®.

#DDW2025 #Gastroenterology #GITwitter #IBD #IBDTwitter #GI #GIHealth
Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Our therapeutic drug monitoring (TDM) Anser menu, which includes assays for infliximab (IFX), adalimumab (ADA), ustekinumab (UST) and vedolizumab (VDZ), has expanded to include risankizumab (RZB). Learn more: prometheuslabs.com/anser/about-th… #IBD #Gastroenterology #GITwitter

Our therapeutic drug monitoring (TDM) Anser menu, which includes assays for infliximab (IFX), adalimumab (ADA), ustekinumab (UST) and vedolizumab (VDZ), has expanded to include risankizumab (RZB). Learn more: prometheuslabs.com/anser/about-th…

#IBD #Gastroenterology #GITwitter
Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Come by DDW booth 2129 to learn more about the newest addition to the Prometheus Laboratories test menu, Respondr TNF. Respondr is the first serogenomic test that provides guidance for therapeutic selection and strategic patient management prior to administration of biologic

Come by DDW booth 2129 to learn more about the newest addition to the Prometheus Laboratories test menu, Respondr TNF. Respondr is the first serogenomic test that provides guidance for therapeutic selection and strategic patient management prior to administration of biologic
Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Here's where you can find Prometheus Laboratories’ latest research today at #DDW2025… Featured at the AGA Basic Science Plenary - Broad Landscape of Antimicrobial and Autoantibody Signatures Reveals Selective Reactivity in The Pre-Clinical Phase of Inflammatory Bowel Disease

Here's where you can find Prometheus Laboratories’ latest research today at #DDW2025…

Featured at the AGA Basic Science Plenary
- Broad Landscape of Antimicrobial and Autoantibody Signatures Reveals Selective Reactivity in The Pre-Clinical Phase of Inflammatory Bowel Disease
Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Did You Know? | 100% of clinicians who participated in our clinical experience program found PredictrPK valuable in aiding adalimumab (ADA) dosing during maintenance and 95% specifically found it useful for therapy escalation. Learn more about how PredictrPK can empower you to

Did You Know? | 100% of clinicians who participated in our clinical experience program found PredictrPK valuable in aiding adalimumab (ADA) dosing during maintenance and 95% specifically found it useful for therapy escalation. Learn more about how PredictrPK can empower you to
Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Here's where you can find Prometheus Laboratories’ latest research today at #DDW2025… Featured at Novel Biomarkers in IBD: - Integrin Alpha V Beta 6 Autoantibodies are a Novel Biomarker for Both Diagnosed and Preclinical Colonic Crohn's Disease (1301; oral presentation at 4

Here's where you can find Prometheus Laboratories’ latest research today at #DDW2025…

Featured at Novel Biomarkers in IBD:
- Integrin Alpha V Beta 6 Autoantibodies are a Novel Biomarker for Both Diagnosed and Preclinical Colonic Crohn's Disease (1301; oral presentation at 4
Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Thank you to everyone who came by at #DDW2025 to discuss how precision-guided dosing with PredictrPK, following therapy selection guided by Respondr, enables comprehensive therapy optimization and supports improved patient outcomes. We’ll see you next year in Chicago!

Thank you to everyone who came by at #DDW2025 to discuss how precision-guided dosing with PredictrPK, following therapy selection guided by Respondr, enables comprehensive therapy optimization and supports improved patient outcomes. We’ll see you next year in Chicago!
Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

If you’re in the Portland area, come visit with our local Regional Technical Specialist, Nikki Bauer, on Saturday, May 10 at the IBDHorizons 2nd City of Roses! She’d love to talk with you about our latest innovations in precision-guided dosing and therapy selection.

If you’re in the Portland area, come visit with our local Regional Technical Specialist, Nikki Bauer, on Saturday, May 10 at the <a href="/IBDHorizons/">IBDHorizons</a> 2nd City of Roses! She’d love to talk with you about our latest innovations in precision-guided dosing and therapy selection.
Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Managing Crohn's disease is easier with the innovative Monitr® Crohn's Disease test. This noninvasive serum test measures and monitors endoscopic disease activity, providing a comprehensive Endoscopic Healing Index (EHI) Score ranging from 0 to 100. The EHI Score helps

Managing Crohn's disease is easier with the innovative Monitr® Crohn's Disease test. This noninvasive serum test measures and monitors endoscopic disease activity, providing a comprehensive Endoscopic Healing Index (EHI) Score ranging from 0 to 100.

The EHI Score helps
Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Today, on World IBD Day 2025, we stand united with the global community to raise awareness about Inflammatory Bowel Disease (IBD). At Prometheus Laboratories, we are dedicated to improving the lives of those affected by Crohn's disease and ulcerative colitis through innovative

Today, on World IBD Day 2025, we stand united with the global community to raise awareness about Inflammatory Bowel Disease (IBD). At Prometheus Laboratories, we are dedicated to improving the lives of those affected by Crohn's disease and ulcerative colitis through innovative
Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Less than 2 weeks to go until San Diego Take Steps, presented by Prometheus Laboratories. This year, it’s being held Sunday, June 1 at 10 a.m. at Liberty Station in Point Loma. If a loved one suffers from Inflammatory Bowel Disease and you’re in the San Diego area, sign up to

Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Less than 2 weeks to go until San Diego Take Steps, presented by Prometheus Laboratories. This year, it’s being held Sunday, June 1 at 10 a.m. at Liberty Station in Point Loma. If a loved one suffers from Inflammatory Bowel Disease and you’re in the San Diego area, sign up to

Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Less than 2 weeks to go until San Diego Take Steps, presented by Prometheus Laboratories. This year, it’s being held Sunday, June 1 at 10 a.m. at Liberty Station in Point Loma. If a loved one suffers from Inflammatory Bowel Disease and you’re in the San Diego area, sign up to

Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Less than 2 weeks to go until San Diego Take Steps, presented by Prometheus Laboratories. This year, it’s being held Sunday, June 1 at 10 a.m. at Liberty Station in Point Loma. If a loved one suffers from Inflammatory Bowel Disease and you’re in the San Diego area, sign up to

Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Less than 2 weeks to go until San Diego Take Steps, presented by Prometheus Laboratories. This year, it’s being held Sunday, June 1 at 10 a.m. at Liberty Station in Point Loma. If a loved one suffers from Inflammatory Bowel Disease and you’re in the San Diego area, sign up to

Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Less than 2 weeks to go until San Diego Take Steps, presented by Prometheus Laboratories. This year, it’s being held Sunday, June 1 at 10 a.m. at Liberty Station in Point Loma. If a loved one suffers from Inflammatory Bowel Disease and you’re in the San Diego area, sign up to

Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Accelerated pre-therapy clearance (>0.326 L/day) and genetic risk for anti-TNF immunogenicity significantly impact therapy response. Before starting an IBD patient on an anti-TNF such as infliximab or adalimumab, use Respondr to predict their likelihood of response. Learn more:

Accelerated pre-therapy clearance (&gt;0.326 L/day) and genetic risk for anti-TNF immunogenicity significantly impact therapy response. Before starting an IBD patient on an anti-TNF such as infliximab or adalimumab, use Respondr to predict their likelihood of response. Learn more:
Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Accelerated pre-therapy clearance (>0.326 L/day) and genetic risk for anti-TNF immunogenicity significantly impact therapy response. Before starting an IBD patient on an anti-TNF such as infliximab or adalimumab, use Respondr to predict their likelihood of response. Learn more:

Accelerated pre-therapy clearance (&gt;0.326 L/day) and genetic risk for anti-TNF immunogenicity significantly impact therapy response. Before starting an IBD patient on an anti-TNF such as infliximab or adalimumab, use Respondr to predict their likelihood of response. Learn more:
Prometheus Laboratories (@prometheuslab) 's Twitter Profile Photo

Did You Know? | Overweight and obese patients with Crohn’s disease who initiate treatment with adalimumab are more likely to have lower trough concentrations and experience treatment failure: journals.lww.com/ajg/abstract/2… Early optimized precision-guided dosing with PredictrPK may

Did You Know? | Overweight and obese patients with Crohn’s disease who initiate treatment with adalimumab are more likely to have lower trough concentrations and experience treatment failure: journals.lww.com/ajg/abstract/2…

Early optimized precision-guided dosing with PredictrPK may